Lively Biotech has obtained optimistic suggestions from regulators on a protocol modification to its ongoing proof-of-concept scientific trial evaluating tasquinimod in sufferers with myelofibrosis, a...
The U.S. Meals and Drug Administration (FDA) has accepted PD-L1 IHC 22C3 pharmDx, Code SK006, as a companion diagnostic to assist establish sufferers with epithelial...
The U.S. Meals and Drug Administration (FDA) has cleared an investigational new drug utility from Scancell Holdings plc for a registrational section...
The U.S. Meals and Drug Administration (FDA) has accepted a supplemental biologics license utility and granted precedence evaluation for Datroway (datopotamab deruxtecan)...
Final week, the U.S. Meals and Drug Administration (FDA) accredited the usage of Darzalex Faspro (daratumumab and hyaluronidase-fihj) together with Velcade (bortezomib),...
